Xylem (XYL) is a buy with strong demand from water scarcity, infrastructure upgrades, PFAS treatment, and promising growth ...

LOS ANGELES, CA– In a groundbreaking achievement set to reshape the future of transplant medicine, Dr. Inderbir S. Gill has led the world’s first successful bladder transplant in a human being ...

Pima County sheriff’s deputies arrested a well-known pedophilia conspiracist Monday morning on charges related to stealing and damaging water tanks belonging to a humanitarian group.

Bladder cancer is a biologically heterogeneous disease, and ongoing efforts in biomarker research aim to support personalized treatment approaches. Circulating tumour DNA is approaching clinical ...

Johnson & Johnson has started a marketing application in the US for TAR-200 as a treatment for non-muscle-invasive bladder cancer (NMIBC).

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product.

Xylem Inc, a United States-based water technology provider and a four-time participant at the annual China International Import Expo (CIIE), will put a new innovation center into operation in Shanghai ...